Skip to content
News Coverage

Six academic centers, The Parker Institute form IRB reliance agreement

The Parker Institute for Cancer Immunotherapy and its six affiliated research institutions have agreed to streamline the review process for faster approval of multicenter clinical trials. This approach is designed to get clinical trials off the ground in weeks, rather than months, saving both time and resources.

Read More

Get Email Updates